Haematopoetic stem cells in MS

September 2007
Multiple Sclerosis (13524585);Sep2007 Supplement 2, Vol. 13, pS21
Academic Journal
The article presents abstracts of medical research which include "Animal studies with haematopoetic and non-haematopoetic bone marrow-derived stem cells: their properties and the scientific basis for clinical applications in multiple sclerosis (MS)," "Present status of hematopoietic stem cells (HSCT) in multiple sclerosis (MS)," and "Immune ablation and autologous stem cell transplantation for aggressive multiple sclerosis: interim 5-year report."


Related Articles

  • Present status of HLA typing for haematopoietic stem cell transplantation in Lithuania. Malickaite, Radvile; Staneviciene, Aldona; Simanaviciene, Stanislava // Acta Medica Lituanica;2005, Vol. 12 Issue 3, p32 

    Objective. The present paper summarizes development of donor search for allotransplantation of haematopoietic stem cells (HSC) in Lithuania during a period of seven years (1998-2005). This paper considers the topics of strategy and methods of histocompatibility typing and creating a legal and...

  • Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Gea-Banacloche, J; Masur, H; da Cunha, C Arns; Chiller, T; Kirchhoff, L V; Shaw, P; Tomblyn, M; Cordonnier, C // Bone Marrow Transplantation;Apr2010, Vol. 45 Issue 4, p806 

    A correction to the article "Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective" that was published in 2009 issue is presented.

  • Stem Cell Update. Gerics, Jennifer // New Mobility;Apr2009, Vol. 20 Issue 187, p18 

    The article reports on the result of the study which assesses the effectiveness of non-myeloablative hematopoietic stem cell transplantation in treating multiple sclerosis (MS). The study was participated by 21 adults with MS where improvement in standard disability scale was observed among 17...

  • Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Saccardi, R.; Kozak, T.; Bocelli-Tyndall, C.; Fassas, A.; Kazis, A.; Havrdova, E.; Carreras, E.; Saiz, A.; L�wenberg, B.; te Boekhorst, P. A. W.; Gualandi, F.; Openshaw, H.; Longo, G.; Pagliai, F.; Massacesi, L.; Deconink, E.; Ouyang, J.; Nagore, F..J. Z.; Besalduch, J.; Lisukov, I. A. // Multiple Sclerosis (13524585);Dec2006, Vol. 12 Issue 6, p814 

    Over the last decade, hematopoietic stem cells transplantation (HSCT) has been increasingly used in the treatment of severe progressive autoimmune diseases. We report a retrospective survey of 183 multiple sclerosis (MS) patients, recorded in the database of the European Blood and Marrow...

  • Intense immunosuppression followed by autologous stem cell transplantation in severe multiple sclerosis. Capello, E.; Saccardi, R.; Murialdo, A.; Gualandi, F.; Pagliai, F.; Bacigalupo, A.; Marmont, A.; Uccelli, A.; Inglese, M.; Bruzzi, P.; Sormani, M.; Cocco, E.; Meucci, G.; Massacesi, L.; Bertolotto, A.; Lugaresi, A.; Merelli, E.; Solari, A.; Filippi, M.; Mancardi, G. // Neurological Sciences;Dec2005 Supplement 4, Vol. 26, ps200 

    Aggressive forms of multiple sclerosis (MS) represent a limited group of demyelinating diseases that rapidly progress to severe disability. Currently available therapies are poorly effective against these clinical entities. Recently, it has been demonstrated that intense immunosuppression...

  • T-cell clones persisting in the circulation after autologous hematopoietic SCT are undetectable in the peripheral CD34+ selected graft. Dubinsky, A. N.; Burt, R. K.; Martin, R.; Muraro, P. A. // Bone Marrow Transplantation;Feb2010, Vol. 45 Issue 2, p325 

    In addition to its established hematological indications, autologous hematopoietic SCT (HSCT) can ameliorate the course of severe autoimmune disorders through a reconditioning of the immune system. We have shown earlier that HSCT determines extensive renewal of the TCR repertoire in multiple...

  • Qualidade de Vida Relacionada à Saúde de Pacientes com Esclerose Múltipla antes do Transplante de Células-Tronco Hematopoéticas. Crovador, Laura Ferreira; Oliveira-Cardoso, Érika Arantes; Mastropietro, Ana Paula; dos Santos, Manoel Antônio // Psicologia: Reflexão e Critica;2013, Vol. 26 Issue 1, p58 

    This study aimed to evaluate quality of life (QoL) and psychological vulnerability (anxiety, stress and depression) of patients with multiple sclerosis (MS) who would undergo Hematopoietic Stem Cell Transplantation (HSCT). The sample consisted of 13 patients. The following instruments were used:...

  • Contents Page.  // Archives of Clinical Neuropsychology;Mar2011, Vol. 26 Issue 2, pNP 

    No abstract available.

  • Treatment Strategies.  // Current Medical Literature: Multiple Sclerosis;2013, Vol. 5 Issue 3, p83 

    The article reviews several articles including "Treatment of cognitive impairment in multiple sclerosis: position paper," by M. P. Amato and colleagues in the "Journal of Neurology, "Early developments of anti-natalizumab antibodies in MS patients," by B. Oliver-Martos in the "Journal of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics